Idvynso (doravirine, islatravir)
New molecular entity
- Region
- 🇺🇸 US
- Active substance
- doravirine, islatravir
- Company
- Msd
- Status
- Approved
- FDA approval
- Mon 20 Apr 2026
- Designations
- New molecular entity
- Application
- NDA216964
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Mon 20 Apr 2026🇺🇸 FDA approval
FDA approves Idvynso (doravirine, islatravir), a new medicine
Same substance in other markets
- 🇪🇺 Delstrigo Authorised · Merck Sharp & Dohme B.V.
- 🇪🇺 Pifeltro Authorised · Merck Sharp & Dohme B.V.
Follow Idvynso
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.